New drug combo aims to shrink pancreatic tumors before surgery
NCT ID NCT03483038
Summary
This study is testing whether a combination of three chemotherapy drugs is safe and effective when given before surgery for pancreatic cancer. The goal is to shrink tumors to make them easier to remove completely. The trial involves 45 adults with newly diagnosed pancreatic cancer that is considered removable by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Orlando Health UF Health Cancer Center
Orlando, Florida, 32806, United States
-
Tallahassee Memorial Health Care
Tallahassee, Florida, 32308, United States
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.